Fig. 1

Fabrication and targeted-therapeutic schematics of ND-MMSNs. a Schematic illustration of the preparation of ND-MMSNs. b Schematic shows that inflammation-activatable ND-MMSNs target inflamed glioma sites and phagocytized D-MMSNs would be released to achieve residual tumor theranostics